1. Home
  2. ETR vs EW Comparison

ETR vs EW Comparison

Compare ETR & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entergy Corporation

ETR

Entergy Corporation

HOLD

Current Price

$114.20

Market Cap

50.9B

Sector

Utilities

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$87.42

Market Cap

49.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETR
EW
Founded
1949
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Industrial Specialties
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.9B
49.9B
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
ETR
EW
Price
$114.20
$87.42
Analyst Decision
Buy
Buy
Analyst Count
18
21
Target Price
$115.25
$96.37
AVG Volume (30 Days)
2.7M
3.9M
Earning Date
04-29-2026
04-23-2026
Dividend Yield
2.23%
N/A
EPS Growth
59.59
N/A
EPS
0.83
0.66
Revenue
$12,946,686,000.00
$6,067,600,000.00
Revenue This Year
$8.40
$13.39
Revenue Next Year
$8.09
$9.81
P/E Ratio
$138.92
$136.27
Revenue Growth
8.98
11.55
52 Week Low
$83.14
$72.30
52 Week High
$118.45
$96.29

Technical Indicators

Market Signals
Indicator
ETR
EW
Relative Strength Index (RSI) 52.34 43.49
Support Level $112.12 $82.02
Resistance Level $117.73 $89.48
Average True Range (ATR) 1.95 2.29
MACD -0.05 -0.58
Stochastic Oscillator 43.14 5.64

Price Performance

Historical Comparison
ETR
EW

About ETR Entergy Corporation

Entergy is a holding company with five regulated vertically integrated utilities that generate and distribute electricity to 3 million customers in Arkansas, Louisiana, Mississippi, and Texas. It is one of the largest power producers in the country with 27 gigawatts of rate-regulated owned and leased power generation capacity. Entergy was the second-largest nuclear owner in the US before it began retiring and selling its plants in the Northeast in 2014. It sold its two small gas utilities in Louisiana in 2025.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: